Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

3.0K
The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
3.0K
Bacterial Phylum Proteobacteria01:26

Bacterial Phylum Proteobacteria

1.1K
Proteobacteria, one of the largest and most diverse bacterial phyla, encompasses a wide range of Gram-negative bacteria distinguished by their outer membrane composed of lipopolysaccharides. These microorganisms exhibit various metabolic capabilities, including phototrophy, chemolithotrophy, and heterotrophy, and thrive in diverse environments from soil to aquatic systems and host-associated niches. The phylum is divided into six classes: Alphaproteobacteria, Betaproteobacteria,...
1.1K
Colonisation of Pathogens01:25

Colonisation of Pathogens

77
Pathogen colonization of host tissues is a critical step in the development of infectious diseases. Various pathogenic microorganisms, including bacteria, fungi, viruses, and protozoa, have evolved complex strategies to attach to, invade, and persist within host environments. These mechanisms enable pathogens to establish infections, evade immune responses, and resist antimicrobial treatments.Attachment to Host CellsIn bacteria, colonization typically begins with adherence to host epithelial...
77
Bacterial Toxins01:12

Bacterial Toxins

148
Bacterial toxins are sophisticated virulence factors that enable pathogenic bacteria to interact with, invade, and damage host tissues. These toxins fall broadly into two types: protein exotoxins, which are secreted into the environment and target specific host receptors, and lipopolysaccharide endotoxins, which are structural components of the bacterial outer membrane released primarily during bacterial lysis or membrane shedding. Exotoxins generally act more selectively, binding to cell...
148
Bacterial Phylum Actinobacteria01:30

Bacterial Phylum Actinobacteria

854
Coryneform bacteria are gram-positive, aerobic, nonmotile rods that exhibit irregular, club-shaped, or V-shaped arrangements. Their V-shape results from snapping division, where the inner cell wall layer forms the cross-wall, while the outer layer remains intact until it ruptures on one side, causing the daughter cells to bend away.The primary genera are Corynebacterium and Arthrobacter. Corynebacterium includes diverse species, ranging from saprophytes to pathogens like Corynebacterium...
854
Bacterial Phylum Bacteroidota01:26

Bacterial Phylum Bacteroidota

885
The phylum Bacteroidota includes over 700 species classified into four primary orders: Bacteroidales, Cytophagales, Flavobacteriales, and Sphingobacteriales. These gram-negative, non-sporulating rods exhibit saccharolytic capabilities and can be aerobic or fermentative, encompassing obligate aerobes, facultative aerobes, and obligate anaerobes. Many species display gliding motility, though some are nonmotile or use flagella. The genus Bacteroides is well-studied due to its significant role in...
885

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Relapse and Emergent Resistance With Novel Short-Course Regimens for Multidrug-Resistant Tuberculosis, United States, 2022-2024.

Open forum infectious diseases·2026
Same author

Safety, tolerability, and preliminary effects of cricket chitin for adults with IBS: a double-blind randomized crossover pilot trial.

Food & function·2025
Same author

Development of an In-Situ Multifrequency Electromagnetic Sensor for Real-Time Microstructure Monitoring in a Continuous Annealing Furnace.

Sensors (Basel, Switzerland)·2025
Same author

Operational considerations of select new treatment recommendations for drug-susceptible and drug-resistant tuberculosis.

Journal of clinical tuberculosis and other mycobacterial diseases·2025
Same author

The 4-Month Isoniazid, Rifapentine, Moxifloxacin, and Pyrazinamide Treatment Regimen for Drug-Susceptible Pulmonary Tuberculosis: A Word of Caution.

American journal of respiratory and critical care medicine·2025
Same author

Contemporary management of multi-drug resistant tuberculosis.

Journal of clinical tuberculosis and other mycobacterial diseases·2025
Same journal

Clinical Trials and Translational Advances in Metabolic Targeting.

Cancer treatment and research·2026
Same journal

Tools and Technologies for Studying Cancer Metabolism.

Cancer treatment and research·2026
Same journal

Cancer and Immune Cells: A Metabolic Battle in the Tumor Microenvironment.

Cancer treatment and research·2026
Same journal

Biomarkers of Cancer Metabolism and Therapeutic Response.

Cancer treatment and research·2026
Same journal

Targeting Metabolism in Cancer Therapy: Inhibitors and Approaches.

Cancer treatment and research·2026
Same journal

Metabolic Reprogramming in Cancer Stem Cells.

Cancer treatment and research·2026
See all related articles

Related Experiment Video

Updated: May 1, 2026

Using a Bacterial Pathogen to Probe for Cellular and Organismic-level Host Responses
08:38

Using a Bacterial Pathogen to Probe for Cellular and Organismic-level Host Responses

Published on: February 22, 2019

5.3K

Bacterial pathogens.

John W Wilson1

  • 1Department of Medicine, Division of Infectious Diseases, Mayo Clinic, 200 First Street, SW, Rochester, MN, 55905, USA, wilson.john@mayo.edu.

Cancer Treatment and Research
|April 8, 2014
PubMed
Summary
This summary is machine-generated.

Bacterial infections are common in cancer patients, with drug-resistant strains posing a growing threat. This review covers common pathogens, clinical syndromes, and management strategies, including antimicrobial resistance in cancer care.

More Related Videos

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

14.6K
Identification of Rare Bacterial Pathogens by 16S rRNA Gene Sequencing and MALDI-TOF MS
06:34

Identification of Rare Bacterial Pathogens by 16S rRNA Gene Sequencing and MALDI-TOF MS

Published on: July 11, 2016

17.1K

Related Experiment Videos

Last Updated: May 1, 2026

Using a Bacterial Pathogen to Probe for Cellular and Organismic-level Host Responses
08:38

Using a Bacterial Pathogen to Probe for Cellular and Organismic-level Host Responses

Published on: February 22, 2019

5.3K
Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

14.6K
Identification of Rare Bacterial Pathogens by 16S rRNA Gene Sequencing and MALDI-TOF MS
06:34

Identification of Rare Bacterial Pathogens by 16S rRNA Gene Sequencing and MALDI-TOF MS

Published on: July 11, 2016

17.1K

Area of Science:

  • Infectious Diseases
  • Oncology
  • Microbiology

Background:

  • Bacterial infections are significant complications in cancer patients.
  • Infection characteristics depend on malignancy type, chemotherapy, and transplantation.
  • Drug-resistant bacteria present an increasing challenge in this population.

Purpose of the Study:

  • To review common bacterial pathogens, Nocardia, and mycobacteria in cancer patients.
  • To discuss clinical syndromes and management of these infections.
  • To address antimicrobial resistance, mechanisms, and therapies.

Main Methods:

  • Literature review of bacterial infections in cancer patients.
  • Discussion of specific pathogens including Nocardia and mycobacteria.
  • Analysis of antimicrobial resistance patterns and treatment strategies.

Main Results:

  • Common bacterial pathogens, Nocardia, and mycobacteria frequently affect cancer patients.
  • Clinical presentations and management vary based on cancer type and treatment.
  • Antimicrobial resistance in both gram-positive and gram-negative bacteria is a critical concern.

Conclusions:

  • Effective management of bacterial infections in cancer requires understanding specific pathogens and resistance patterns.
  • Addressing antimicrobial resistance is crucial for improving outcomes in immunocompromised cancer patients.
  • Comprehensive strategies are needed for the prevention and treatment of bacterial infections in oncology settings.